Tabula Rasa HealthCare, Inc. – NASDAQ:TRHC
Tabula Rasa HealthCare stock price monthly change
Tabula Rasa HealthCare stock price quarterly change
Tabula Rasa HealthCare stock price yearly change
Tabula Rasa HealthCare key metrics
Market Cap | 284.03M |
Enterprise value | 311.26M |
P/E | -1.71 |
EV/Sales | 1.03 |
EV/EBITDA | -6.12 |
Price/Sales | 0.44 |
Price/Book | -2.34 |
PEG ratio | 0.02 |
EPS | -2.47 |
Revenue | 338.12M |
EBITDA | -17.38M |
Income | -61.17M |
Revenue Q/Q | 24.02% |
Revenue Y/Y | 8.38% |
Profit margin | -49.25% |
Oper. margin | -23.03% |
Gross margin | 22.34% |
EBIT margin | -23.03% |
EBITDA margin | -5.14% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeTabula Rasa HealthCare stock price history
Tabula Rasa HealthCare stock forecast
Tabula Rasa HealthCare financial statements
| Sep 2022 | 77.10M | -25.88M | -33.57% |
|---|---|---|---|
| Dec 2022 | 82.70M | -18.37M | -22.21% |
| Mar 2023 | 88.27M | -7.07M | -8.01% |
| Jun 2023 | 90.03M | -9.85M | -10.94% |
| 2025 | 468.88M | -7.95M | -1.7% |
|---|
Analysts Price target
Financials & Ratios estimates
| Sep 2022 | 403846000 | 435.49M | 107.84% |
|---|---|---|---|
| Dec 2022 | 384149000 | 441.18M | 114.85% |
| Mar 2023 | 355597000 | 426.46M | 119.93% |
| Jun 2023 | 355937000 | 434.01M | 121.94% |
| Sep 2022 | 913K | 112.02M | -58.30M |
|---|---|---|---|
| Dec 2022 | -2.39M | -2.37M | -1.06M |
| Mar 2023 | -8.75M | 180K | -403K |
| Jun 2023 | 5.10M | -5.29M | -33K |
Tabula Rasa HealthCare alternative data
| Aug 2023 | 1,027 |
|---|---|
| Sep 2023 | 1,027 |
| Oct 2023 | 1,027 |
| Nov 2023 | 1,027 |
| Dec 2023 | 1,027 |
| Jan 2024 | 1,027 |
| Feb 2024 | 1,027 |
| Mar 2024 | 1,027 |
| Apr 2024 | 1,027 |
| May 2024 | 1,027 |
| Jun 2024 | 1,027 |
| Jul 2024 | 1,027 |
Tabula Rasa HealthCare other data
| Period | Buy | Sel |
|---|---|---|
| Jan 2022 | 0 | 21045 |
| Mar 2022 | 27000 | 0 |
| Jul 2022 | 1352554 | 0 |
| Dec 2022 | 11500 | 10000 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Option | GREENHALGH MICHAEL officer: CHIEF OP.. | Common Stock | 25,000 | $3.11 | $77,750 | ||
Option | GREENHALGH MICHAEL officer: CHIEF OP.. | Employee Stock Option (right to buy) | 25,000 | $3.11 | $77,750 | ||
Option | ADAMS BRIAN W officer: CHIEF EX.. | Common Stock | 42,153 | $3.11 | $131,096 | ||
Option | ADAMS BRIAN W officer: CHIEF EX.. | Employee Stock Option (right to buy) | 42,153 | $3.11 | $131,096 | ||
Purchase | CANCRO THOMAS officer: CHIEF FINANCIAL OFFICER | Common Stock | 11,500 | $4.34 | $49,910 | ||
Sale | PURCELL MICHAEL J. director | Common Stock | 10,000 | $4.26 | $42,600 | ||
Purchase | INDABA CAPITAL MANAGEMENT, L.P. 10 percent owner | Common Stock | 59,262 | $4.28 | $253,641 | ||
Purchase | INDABA CAPITAL MANAGEMENT, L.P. 10 percent owner | Common Stock | 90,000 | $4.43 | $398,970 | ||
Purchase | INDABA CAPITAL MANAGEMENT, L.P. 10 percent owner | Common Stock | 103,292 | $4.06 | $419,469 | ||
Purchase | INDABA CAPITAL MANAGEMENT, L.P. 10 percent owner | Common Stock | 100,000 | $4.22 | $422,100 |
| Patent |
|---|
Grant Filling date: 8 May 2020 Issue date: 14 Jun 2022 |
Application TREATMENT METHODS HAVING REDUCED DRUG-RELATED TOXICITY AND METHODS OF IDENTIFYING THE LIKELIHOOD OF PATIENT HARM FROM PRESCRIBED MEDICATIONS Filling date: 7 Jan 2021 Issue date: 13 May 2021 |
Grant Utility: Treatment methods having reduced drug-related toxicity and methods of identifying the likelihood of patient harm from prescribed medications Filling date: 19 May 2017 Issue date: 12 Jan 2021 |
Application Filling date: 8 May 2020 Issue date: 1 Oct 2020 |
Application TREATMENT METHODS HAVING REDUCED DRUG-RELATED TOXICITY AND METHODS OF IDENTIFYING THE LIKELIHOOD OF PATIENT HARM FROM PRESCRIBED MEDICATIONS Filling date: 19 May 2017 Issue date: 26 Sep 2019 |
| Quarter | Transcript |
|---|---|
| Q1 2023 9 May 2023 | Q1 2023 Earnings Call Transcript |
| Q4 2022 7 Mar 2023 | Q4 2022 Earnings Call Transcript |
| Q3 2022 4 Nov 2022 | Q3 2022 Earnings Call Transcript |
| Q2 2022 5 Aug 2022 | Q2 2022 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
Dr. Calvin H. Knowlton BSc Pharm, MDiv, Ph.D. (1950) Co-Founder, Chairman & Chief Executive Officer | $542,930 |
Dr. Orsula Voltis Knowlton BScPharm, M.B.A., MBA, Pharm.D., PharmD (1969) Co-Founder, Pres, Chief Marketing & New Bus. Devel. Officer and Director | $419,450 |
| Mr. Brian W. Adams (1982) Co-Pres, Chief Financial Officer & Sec. | $407,830 |
| Mr. Michael Greenhalgh (1962) Chief Operating Officer | $407,530 |
-
When is Tabula Rasa HealthCare's next earnings date?
Unfortunately, Tabula Rasa HealthCare's (TRHC) next earnings date is currently unknown.
-
Does Tabula Rasa HealthCare pay dividends?
No, Tabula Rasa HealthCare does not pay dividends.
-
How much money does Tabula Rasa HealthCare make?
Tabula Rasa HealthCare has a market capitalization of 284.03M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 9.58% to 299.52M US dollars.
-
What is Tabula Rasa HealthCare's stock symbol?
Tabula Rasa HealthCare, Inc. is traded on the NASDAQ under the ticker symbol "TRHC".
-
What is Tabula Rasa HealthCare's primary industry?
Company operates in the Healthcare sector and Medical - Healthcare Information Services industry.
-
How do i buy shares of Tabula Rasa HealthCare?
Shares of Tabula Rasa HealthCare can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Tabula Rasa HealthCare's key executives?
Tabula Rasa HealthCare's management team includes the following people:
- Dr. Calvin H. Knowlton BSc Pharm, MDiv, Ph.D. Co-Founder, Chairman & Chief Executive Officer(age: 75, pay: $542,930)
- Dr. Orsula Voltis Knowlton BScPharm, M.B.A., MBA, Pharm.D., PharmD Co-Founder, Pres, Chief Marketing & New Bus. Devel. Officer and Director(age: 56, pay: $419,450)
- Mr. Brian W. Adams Co-Pres, Chief Financial Officer & Sec.(age: 43, pay: $407,830)
- Mr. Michael Greenhalgh Chief Operating Officer(age: 63, pay: $407,530)
-
Is Tabula Rasa HealthCare founder-led company?
Yes, Tabula Rasa HealthCare is a company led by its founders Dr. Calvin H. Knowlton BSc Pharm, MDiv, Ph.D. and Dr. Orsula Voltis Knowlton BScPharm, M.B.A., MBA, Pharm.D., PharmD.
-
How many employees does Tabula Rasa HealthCare have?
As Jul 2024, Tabula Rasa HealthCare employs 1,027 workers.
-
When Tabula Rasa HealthCare went public?
Tabula Rasa HealthCare, Inc. is publicly traded company for more then 8 years since IPO on 29 Sep 2016.
-
What is Tabula Rasa HealthCare's official website?
The official website for Tabula Rasa HealthCare is tabularasahealthcare.com.
-
Where are Tabula Rasa HealthCare's headquarters?
Tabula Rasa HealthCare is headquartered at 228 Strawbridge Drive, Moorestown, NJ.
-
How can i contact Tabula Rasa HealthCare?
Tabula Rasa HealthCare's mailing address is 228 Strawbridge Drive, Moorestown, NJ and company can be reached via phone at +86 66482767.
Tabula Rasa HealthCare company profile:
Tabula Rasa HealthCare, Inc.
tabularasahealthcare.comNASDAQ
1,027
Medical - Healthcare Information Services
Healthcare
Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise medication therapy management software, a cloud-based platform designed to aid in the identification and resolution of medication and health-related problems. The company also provides TruChart that offers electronic health records (EHR), care coordination, and financial management in one program allowing Programs of All-Inclusive Care for the Elderly (PACE) to track measurable outcomes in defined timeframes for the populations they serve; and PACElogic, which delivers sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination and planning, integration with community-based providers, and various federal and state that requires reporting. In addition, it offers DoseMeRx, a decision support software that leverages clinically validated pharmacokinetic drug models, patient characteristics, drug concentrations, and genotypes to guide dose optimization; and PrescribeWellness, a PrescribeWellness, a patient engagement center platform. Further, the company provides clinical pharmacist collaboration, prescription fulfillment and adherence packaging, and pharmacy benefit management services, as well as health plan management services, including risk adjustment and third party administrator services. As of December 31, 2021, it served approximately 150 healthcare organizations; and 350 health plans and approximately 18,000 retail pharmacies. The company provides cloud-based software applications to assist prescribers and pharmacists. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.
Moorestown, NJ 08057
CIK: 0001651561
ISIN: US8733791011
CUSIP: 873379101
